These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. Cutting edge: Immunosuppressant as adjuvant for tolerogenic immunization. Kang Y, Xu L, Wang B, Chen A, Zheng G. J Immunol; 2008 Apr 15; 180(8):5172-6. PubMed ID: 18390698 [Abstract] [Full Text] [Related]
34. pH-Responsive Poly(D,L-lactic-co-glycolic acid) Nanoparticles with Rapid Antigen Release Behavior Promote Immune Response. Liu Q, Chen X, Jia J, Zhang W, Yang T, Wang L, Ma G. ACS Nano; 2015 May 26; 9(5):4925-38. PubMed ID: 25898266 [Abstract] [Full Text] [Related]
36. The immunogenicity-enhancing effect of emulsion vaccine adjuvants is independent of the dispersion type and antigen release rate--a revisit of the role of the hydrophile-lipophile balance (HLB) value. Yang YW, Wei AC, Shen SS. Vaccine; 2005 Apr 08; 23(20):2665-75. PubMed ID: 15780450 [Abstract] [Full Text] [Related]
37. Tocopherol Emulsions as Functional Autoantigen Delivery Vehicles Evoke Therapeutic Efficacy in Experimental Autoimmune Encephalomyelitis. Griffin JD, Christopher MA, Thati S, Salash JR, Pressnall MM, Weerasekara DB, Lunte SM, Berkland CJ. Mol Pharm; 2019 Feb 04; 16(2):607-617. PubMed ID: 30615457 [Abstract] [Full Text] [Related]
38. Self-adjuvanting nanoemulsion targeting dendritic cell receptor Clec9A enables antigen-specific immunotherapy. Zeng B, Middelberg AP, Gemiarto A, MacDonald K, Baxter AG, Talekar M, Moi D, Tullett KM, Caminschi I, Lahoud MH, Mazzieri R, Dolcetti R, Thomas R. J Clin Invest; 2018 May 01; 128(5):1971-1984. PubMed ID: 29485973 [Abstract] [Full Text] [Related]
39. Spaceflight impairs antigen-specific tolerance induction in vivo and increases inflammatory cytokines. Chang TT, Spurlock SM, Candelario TL, Grenon SM, Hughes-Fulford M. FASEB J; 2015 Oct 01; 29(10):4122-32. PubMed ID: 26085131 [Abstract] [Full Text] [Related]